compared to isdn , the two longer-lived metabolites isosorbide-2- and isosorbide-5-mononitrates ( is-2-mn , is-5-mn ) appear remarkably different in terms of antiplatelet potency in vitro ( minimum effective concentrations 10 ( -7 ) -10 ( -6 ) m for is-2-mn , 10 ( -4 ) m for is-5-mn , for adp-and adrenaline-induced aggregation and thromboxane ( tx ) b2 production ) .
C0022252
isdn
C0064079
isosorbide-5-mononitrates